These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32244208)

  • 1. Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2021 Mar; 134(3):1091-1101. PubMed ID: 32244208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; Mandonnet E; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2022 Jan; 136(1):45-55. PubMed ID: 34243150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
    J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.
    Sonabend AM; Zacharia BE; Cloney MB; Sonabend A; Showers C; Ebiana V; Nazarian M; Swanson KR; Baldock A; Brem H; Bruce JN; Butler W; Cahill DP; Carter B; Orringer DA; Roberts DW; Sagher O; Sanai N; Schwartz TH; Silbergeld DL; Sisti MB; Thompson RC; Waziri AE; Ghogawala Z; McKhann G
    Neurosurgery; 2017 Apr; 80(4):590-601. PubMed ID: 27509070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map.
    Hendriks EJ; Idema S; Hervey-Jumper SL; Bernat AL; Zwinderman AH; Barkhof F; Vandertop WP; Mandonnet E; Duffau H; Berger MS; De Witt Hamer PC
    Neurosurgery; 2019 Aug; 85(2):E304-E313. PubMed ID: 30423155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.
    Marko NF; Weil RJ; Schroeder JL; Lang FF; Suki D; Sawaya RE
    J Clin Oncol; 2014 Mar; 32(8):774-82. PubMed ID: 24516010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
    Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
    Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
    Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
    Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.